Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002764982 | SCV003759416 | uncertain significance | Inborn genetic diseases | 2022-06-06 | criteria provided, single submitter | clinical testing | The c.9534T>G (p.F3178L) alteration is located in exon 50 (coding exon 50) of the DNAH9 gene. This alteration results from a T to G substitution at nucleotide position 9534, causing the phenylalanine (F) at amino acid position 3178 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |